COMMUNIQUÉS West-GlobeNewswire

Pixium Vision to host KOL Meeting on March 5, 2019 in Paris
28/02/2019
Paris, France. February 28, 2019 – 7.00 AM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more [...]
Pixium Vision organise un KOL Meeting le 5 Mars 2019 à Paris
28/02/2019
Paris, 28 février 2019 – 7h00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon [...]
Abattis Provides Update on Conference Call
28/02/2019
VANCOUVER, British Columbia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) provides the following update on the Company’s recent trading halt and [...]
Alder BioPharmaceuticals, Inc. Prices Public Offering of Common Stock
28/02/2019
BOTHELL, Wash., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]
Kaleido Biosciences Announces Pricing of Initial Public Offering
28/02/2019
LEXINGTON, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]
Neon Therapeutics to Present at the American Association for Cancer Research Annual Meeting
28/02/2019
CAMBRIDGE, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced upcoming presentations at [...]
Dentsply Sirona Declares Quarterly Cash Dividend
28/02/2019
YORK, Pa., Feb. 27, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.0875 [...]
Gritstone Oncology Announces Oral Presentation on MHC Class II Antigen Prediction at the AACR Annual Meeting in April 2019
28/02/2019
-- MHC Class II Antigen Prediction by Gritstone’s Proprietary Artificial Intelligence Platform EDGE TM Shows Significant Improvement Over Standard Prediction Tools -- -- EDGE Enables Identification of Neoantigen [...]
Helix BioPharma Corp. and Moffitt Cancer Center to Present at the AACR Annual Meeting 2019 in Atlanta
27/02/2019
Improving survival in pancreatic cancer using Doxorubicin in combination with L-DOS47 RICHMOND HILL, Ontario, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an [...]
Syneos Health Delays Fourth Quarter and Year End 2018 Earnings Release Date and Conference Call
27/02/2019
MORRISVILLE, N.C., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH) announced today that it has delayed its previously announced earnings release and conference call to allow additional time to complete [...]
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2018 Results and Provides First Quarter and Full Year 2019 Guidance
27/02/2019
Net new business of $667.3 million in the fourth quarter; Net book-to-bill of 1.30 $729.6 million of revenue in the fourth quarter; 11.2% growth at actual foreign exchange rates and 12.0% growth on a constant currency [...]
Atara Biotherapeutics Announces Presentations Highlighting Next-Generation CAR T Platform and Mesothelin-Targeted CAR T Clinical Results at American Association of Cancer Research (AACR) Annual Meeting 2019
27/02/2019
Atara to present off-the-shelf, allogeneic CAR T proof-of-concept results demonstrating Epstein-Barr virus (EBV)-specific T cells expressing chimeric antigen receptors Memorial Sloan Kettering collaborators to present [...]
CytomX Therapeutics Announces Presentations at the American Association for Cancer Research Annual Meeting 2019
27/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Affimed to Present Data on AFM13 and AFM24 at AACR Annual Meeting 2019
27/02/2019
Heidelberg, Germany, February 27, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to improving patient outcomes through the power of the innate immune system, today announced [...]
Amedisys Reports Fourth Quarter and Year End 2018 Financial Results Issues 2019 Guidance
27/02/2019
BATON ROUGE, La., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period and year ended December 31, 2018. Three Month Periods Ended December 31, [...]
Canopy Rivers Reports Third Quarter Financial Highlights and Provides Current Corporate Update
27/02/2019
TORONTO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) today released its financial results for the three and nine months ended December 31, 2018. The Company’s [...]
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2019
27/02/2019
Presentations will feature data on 1) CD38-targeted ETB TAK-169, 2) CD20-targeted ETB MT-3724 in combination with chemotherapy or IMiDs, 3) PD-L1-targeted ETB for direct cell kill approach to PD-L1 expressing cancers, 4 [...]
LHC Group Announces Fourth Quarter 2018 Financial Results
27/02/2019
2019 Guidance Highlights Strong Earnings Accretion from Almost Family Acquisition and Contributions from Joint Ventures LAFAYETTE, La., Feb. 27, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced its [...]
CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2019 Annual Meeting
27/02/2019
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]

Pages